MiMedx® is a developer, processor, manufacturer, and marketer of patent protected biomaterial products and tissues, including EpiFix® and AmnioFix® dehydrated Amnion/Chorion Membrane Allografts. Both products deliver human extracellular matrix components, essential growth factors, and specialized mediating cytokines to modulate inflammation, reduce scar tissue formation, and enhance soft tissue healing.